Acambis Financial Statements
Acambis Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Acambis Income Statement
| 2006 | 2005 | 2004 | |
|---|---|---|---|
| Revenue ($ mil.) | 60.5 | 85.7 | 164.7 |
| Gross Profit ($ mil.) | -- | 38.2 | 98.6 |
| Operating Income ($ mil.) | -- | (37.5) | 59.5 |
| Total Net Income ($ mil.) | -- | (34.9) | 45.5 |
| Diluted EPS (Net Income) | -- | (55.97) | 35.06 |
Acambis Competitive Intelligence
| Merck | Sanofi Pasteur | Wyeth Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 24,197.7 | 3,341.8 | 16,884.2 |
| Employees | 59,800 | 9,808 | 4,500 |
| Market Cap ($ mil.) | 80,881.2 | -- | -- |
